Maze TherapeuticsMAZE
那斯達克 · USD
13.50
-0.10
(-0.74%)
盤中 08/14 10:35 (UTC+8)
08/14 10:35 (UTC+8)
Maze TherapeuticsMAZE
13.50
-0.10
(-0.74%)
財務數據
損益表
- -
- 0.00
- 0.00
- 0.00
- 1.65
- 0.03
- -
- -
- 0.00
- -
- -
- -
- -
- -
- -98.48
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2022/Q4 | |
營業收入淨額 | 0 | - | - | 2,500 | 165,000 | 0 | 0 | 0 | - |
營業成本 | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | 0 | 0 | 0 | - |
營業費用 | - | - | - | 26,729 | 25,445 | 28,014 | 23,051 | 25,228 | 111,026 |
研發費用 | - | 27,580 | 22,216 | 19,857 | 19,546 | 21,877 | 16,045 | 19,458 | 88,192 |
推銷及管理費用 | - | 7,821 | 7,510 | 6,872 | 5,899 | 6,137 | 7,006 | 5,770 | 22,834 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - |
營業利益 | -36,474 | -35,401 | -29,726 | -24,229 | 139,555 | -28,014 | -23,051 | -25,228 | -111,026 |
其他收入及費用 | - | 2,615 | -128 | - | - | - | - | - | -372 |
利息費用 | - | - | - | - | - | - | - | - | - |
稅前純益 | -33,679 | -32,786 | -29,854 | -25,031 | 140,782 | -32,494 | -26,577 | -24,747 | - |
所得稅 | 0 | - | -275 | -279 | - | - | - | 0 | - |
稅後純益 | -33,679 | -32,786 | -29,579 | -24,752 | 139,056 | -32,494 | -26,577 | -24,747 | -114,940 |
基本每股稅後盈餘(元) | -0.77 | -1.15 | -1.02 | - | - | -0.93 | - | - | - |
稀釋每股稅後盈餘(元) | -0.77 | -1.15 | -1.42 | - | - | -0.93 | - | - | - |
基本平均股數(千股) | 43797.00 | 28628.00 | 43776.00 | - | - | 34970.00 | - | - | - |
稀釋平均股數(千股) | 43797.00 | 28628.00 | 43776.00 | - | - | 35400.00 | - | - | - |
還原基本每股稅後盈餘(元) | -0.77 | -1.15 | -1.02 | - | - | -0.93 | - | - | - |
還原稀釋每股稅後盈餘(元) | -0.77 | -1.15 | -1.42 | - | - | -0.93 | - | - | - |
還原基本平均股數(千股) | 43,797 | 28,628 | 43,776 | - | - | 34,970 | - | - | - |
還原稀釋平均股數(千股) | 43,797 | 28,628 | 43,776 | - | - | 35,400 | - | - | - |
EBITDA(千元) | -33,679 | -32,102 | -29,149 | -24,243 | 139,910 | -31,544 | -25,601 | -23,743 | -111,120 |